Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Frontline Therapy of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Rituximab: The Stanford University Experience

Ranjana H. Advani, MD, Sandra J. Horning, MD, Richard T. Hoppe, MD, Sarah Daadi, John Allen, Yasodha Natkunam, MD, PhD, Alex McMillan, PhD, Nancy L. Bartlett, MD

Blood (2011) 118 (21): 2686.

https://doi.org/10.1182/blood.V118.21.2686.2686

Published: 2011

Journal Articles

Chronic Graft-Versus-Host Disease Responds to Imatinib and Pre Transplant/Donor Anti-PDGFRA Antibodies Predict for Chronic Graft-Versus-Host Disease Development

George L. Chen, MD, Sally Arai, MD, Mary E.D. Flowers, MD, Joanne M Otani, RN, MSN, BS, Marc Coram, PhD, Alex McMillan, PhD, Judith A Shizuru, PhD, MD, Laura Johnston, MD, David Miklos, MD, PhD

Blood (2010) 116 (21): 2320.

https://doi.org/10.1182/blood.V116.21.2320.2320

Published: 2010

Journal Articles

A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis.

George L. Chen, MD, Sally Arai, MD, Mary E.D. Flowers, MD, Joanne Otani, RN, MSN, Ethan C. Cheng, Alex McMillan, PhD, Wen-Kai Weng, MD, PhD, Judith Shizuru, PhD, MD, Laura Johnston, MD, David Miklos, MD, PhD

Blood (2009) 114 (22): 3304.

https://doi.org/10.1182/blood.V114.22.3304.3304

Published: 2009

Journal Articles

Long Term Results of Autologous Hematopoietic Cell Transplantation (AHCT) for Peripheral T Cell Lymphoma: The Stanford Experience.

Andy I. Chen, MD, PhD, Alex McMillan, PhD, Robert S. Negrin, MD, Sandra J. Horning, MD, Ginna G. Laport, MD

Blood (2007) 110 (11): 1906.

https://doi.org/10.1182/blood.V110.11.1906.1906

Published: 2007

Journal Articles

International MDS Risk Analysis Workshop (IMRAW)/IPSS Re-Analyzed: Impact of Depth of Cytopenias on Clinical Outcomes in MDS.

Jelena M. Kao, MD, Alex McMillan, PhD, Peter L. Greenberg, MD

Blood (2007) 110 (11): 2457.

https://doi.org/10.1182/blood.V110.11.2457.2457

Published: 2007

NARROW

Frontline Therapy of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Rituximab: The Stanford University Experience

Chronic Graft-Versus-Host Disease Responds to Imatinib and Pre Transplant/Donor Anti-PDGFRA Antibodies Predict for Chronic Graft-Versus-Host Disease Development

A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis.

Long Term Results of Autologous Hematopoietic Cell Transplantation (AHCT) for Peripheral T Cell Lymphoma: The Stanford Experience.

International MDS Risk Analysis Workshop (IMRAW)/IPSS Re-Analyzed: Impact of Depth of Cytopenias on Clinical Outcomes in MDS.

Email alerts

ASH Publications

American Society of Hematology

Frontline Therapy of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Rituximab: The Stanford University Experience

Chronic Graft-Versus-Host Disease Responds to Imatinib and Pre Transplant/Donor Anti-PDGFRA Antibodies Predict for Chronic Graft-Versus-Host Disease Development

A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis.

Long Term Results of Autologous Hematopoietic Cell Transplantation (AHCT) for Peripheral T Cell Lymphoma: The Stanford Experience.

International MDS Risk Analysis Workshop (IMRAW)/IPSS Re-Analyzed: Impact of Depth of Cytopenias on Clinical Outcomes in MDS.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only